0.05Open0.05Pre Close0 Volume6 Open Interest5.00Strike Price0.00Turnover769.86%IV354.95%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1343Delta0.2049Gamma22.20Leverage Ratio-0.0191Theta0.0000Rho2.98Eff Leverage0.0003Vega
LAVA Therapeutics Stock Discussion
📊⚡️📊
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics (LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet